Bioprofiles of gram-negative bacteria with recurrent lower urinary tract infection
https://doi.org/10.17021/1992-6499-2025-3-78-87
Abstract
Uncomplicated recurrent lower urinary tract infection is a pressing problem not only for urologists, but also for clinical microbiologists. Currently, there are no quantitative indicators of diagnostically significant bacteriuria levels, which complicates the interpretation of bacteriological test results. The chronic and recurrent nature of the disease may be associated not only with quantitative, but also with qualitative (pathogenic, persistent) characteristics of uropathogens.
Objective: to study the relationship between hemolytic, antilysozyme activities, extended-spectrum βlactamase production with virulence genes in gram-negative uropathogens in uncomplicated recurrent lower urinary tract infection in women. Proven pathogens, representatives of gram-negative microbiota with a predominance of E. coli (74.2 %), were isolated from the urine of 62 patients with uncomplicated recurrent lower urinary tract infection. In all strains isolated from urine the virulence genes were determined: papA, papE/F, papGII, afa, bmaE, fyuA, iutA, feoB, kpsMII, usp. These virulence genes were responsible for adhesion, iron absorption system, capsule synthesis and uropathogenic specific protein. In parallel, hemolytic activity, antilysozyme activity, as well as production of extendedspectrum β-lactamases were determined in the isolated strains. The study showed that strains of gram-negative bacteria isolated from the urine of patients in most cases had hemolytic activity (61.3 %), production of extended-spectrum βlactamases (56.5 %). All strains had antilysozyme activity and in all of them the studied virulence genes were presented. The presence of hemolytic activity was reliably associated with such virulence genes as feoB, fyuA, usp, papA, kpsMII; the presence of antilysozyme activity was associated with papA, afa and fyuA; production of extended-spectrum βlactamases – with papA and fyuA. Common virulence genes for which a relationship with the presence of hemolytic activity, antilysozyme activity, production of extended-spectrum β-lactamases were papA and fyuA. The detected reliable correlation relationships between the studied features with certain virulence genes more likely can lead to a chronic and recurrent course of the disease and maintenance of the infectious and inflammatory process in the urinary tract.
About the Authors
Ju. L. NabokaРоссия
Yulia L. Naboka, Dr. Sci. (Med.), Professor, Head of the Department
Rostov-on-Don
I. A. Gudima
Россия
Irina A. Gudima, Dr. Sci. (Med.), Associate Professor, Professor of the Department
Rostov-on-Don
M. I. Kogan
Россия
Mikhail I. Kogan, Dr. Sci. (Med.), Professor, Head of the Department, Honored Scientist of Russian Federation
Rostov-on-Don
K. T. Jalagoniya
Россия
Ksenia T. Jalagoniya, Cand. Sci. (Med.), Assistant of the Department
Rostov-on-Don
M. L. Chernitskaya
Россия
Marina L. Chernitskaya, Cand. Sci. (Med.), Associate Professor of the Department
Rostov-on-Don
E. V. Kudrya
Россия
Elena V. Kudrya, Cand. Sci. (Med.), Assistant of the Department
Rostov-on-Don
E. V. Ivannikova
Россия
Evgenia V. Ivannikova, Cand. Sci. (Med.), Associate Professor of the Department
Rostov-on-Don
N. N. Beloglasova
Россия
Natalia N. Beloglasova, Assistant of the Department
Rostov-on-Don
References
1. Federalnyye klinicheskiye rekomendatsii “Antimikrobnaya terapiya i profilaktika infektsiy pochek, mochevyvodyashchikh putey i muzhskikh polovykh organov” = Federal clinical guidelines “Antimicrobial therapy and prevention of infections of the kidneys, urinary tract and male genital organs”. Ed. by Yu. G. Alyaev, O. I. Apolikhin, D. Yu. Pushkar. Moscow; 2022: 126 p. (In Russ.).
2. Kärkkäinen U. M., Ikäheimo R., Katila M. L., Siitonen A. Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up. Scandinavian Journal of Infectious Diseases. 2000; 32 (5): 495–499. doi: 10.1080/003655400458767.
3. Malone-Lee J. Cystitis. Unmasked. 1st Edition. London: TFM; 2021: 350 p.
4. EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. EAU Guidelines Office, Arnhem, the Netherlands. URL: https://uroweb.org/guidelines.
5. Naboka Y. L., Mavzyiutov A. R., Kogan M. I., Gudima I. A., Ivanov S. N., Naber K. G. Does Escherichia coli have pathogenic potential at a low level of bacteriuria in recurrent, uncomplicated urinary tract infection? International Journal of Antimicrobial Agents. 2020; 56 (1): 105983. doi: 10.1016/j.ijantimicag.2020.105983.
6. Bukharin O. V., Valyshev A. V., Gilmutdinova F. G. Ekologiya mikroorganizmov cheloveka = Ecology of human microorganisms. Ekaterinburg: Ural Branch of the RAS; 2006: 477 p. (In Russ.)
7. Kartashova O. L., Pashinina O. A., Pashkova T. M., Gritsenko V. A., Mikhaylenko S. V. Bioprofiles of Staphylococcus spp. isolated from prostate secretion in men with chronic bacterial prostatitis. Tikhookeanskiy meditsinskiy zhurnal = Pacific Medical Journal. 2023; 91 (1): 70–74. doi: 10.34215/1609-1175-2023-1-70-74 (In Russ.).
8. Flores-Oropeza M. A., Ochoa S. A., Cruz-Córdova A., Chavez-Tepecano R., Martínez-Peñafiel E., RembaoBojórquez D., Zavala-Vega S., Hernández-Castro R., Flores-Encarnacion M., Arellano-Galindo J., Vélez D., Xicohtencatl-Cortes J. Comparative genomic analysis of uropathogenic Escherichia coli strains from women with recurrent urinary tract infection. Frontiers in Microbiology. 2024; 24 (14): 1340427. doi: 10.3389/fmicb.2023.1340427.
9. Jiang L., Wang H., Luo L., Pang X., Liu T., Sun L., Zhang G. Urogenital microbiota-driven virulence factor genes associated with recurrent urinary tract infection. Frontiers in Microbiology. 2024; 7 (15): 1344716. doi: 10.3389/fmicb.2024.1344716.
10. Naziriнаправлено Z., Derakhshandeh A., Hajirajabi M., Abbasi F., Moezzi M.S., Shirmohamadi Sosfad A. Molecular typing and virulence characteristics of Escherichia coli strains isolated from hospital and community acquired urinary tract infections. Molecular Biology Reports. 2024; 51 (1): 509. doi: 10.1007/s11033-024-09485-7.
11. Kozlov R. S., Menshikov V. V., Mikhaylova V. S. Clinical guidelines “Bacteriological analysis of urine” = Clinical guidelines “Bacteriological analysis of urine”. Moscow; 2014: 33 p. (In Russ.).
12. Kogan M. I., Naboka Yu. L., Gudima I. A., Rymashevskiy A. N., Vorob'eva N. V., Rymashevskiy M. A. Microbiota of freshly excreted midstream urine of women in the first trimester of pregnancy (pilot study). Problemy reproduktsii = Russian Journal of Human Reproduction. 2023; 29 (5): 73–78. doi: 10.17116/repro20232905173 (In Russ.).
13. Bukharin O. V. Persistence of bacterial pathogens as a result of host-parasite relationships. Zhurnal mikrobiologii = Journal of Microbiology. 1997; 4: 3–9 (In Russ.).
14. Giske K. G., Martines-Martines L., Kanton R. EUCAST Guidelines for the identification of resistance mechanisms and resistance of particular clinical and/or epidemiological significance. Version 2.01. Moscow; 2017: 58 p. (In Russ.).
15. Jalali H. R., Pourbakhsh A., Fallah F., Eslami G. Genotyping of virulence factors of uropathogenic Escherichia coli by PCR. Nova Biomedical. 2015; 3 (4): 177–181. doi: 10.22037/nbm.v3i4.8036.
16. Salvador E., Wagenlehner F., Köhler C.D., Mellmann A., Hacker J., Svanborg C. Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infection and Immunity. 2012; 80 (2): 668–678. doi: 10.1128/IAI.06191-11.
17. Wang M. C., Tseng C. C., Wu A. B., Lin W. H., Teng C. H., Yan J. J., Wu J. J. Bacterial characteristics and glycemic control in diabetic patients with Escherichia coli urinary tract infection. Journal of Microbiology, Immunology and Infection. 2013; 46 (1): 24–29. doi: 10.1016/j.jmii.2011.12.024
18. Sabaté M., Moreno E., Pérez T., Andreu A., Prats G. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clinical Microbiology and Infection. 2006; 12 (9): 880–886. doi: 10.1111/j.1469-0691.2006.01461.x.
19. Hadifar S., Moghoofei M., Nematollahi S., Ramazanzadeh R., Sedighi M., Salehi-Abargouei A., Miri A. Epidemiology of multidrug resistant uropathogenic Escherichia coli in Iran: a systematic review and meta-analysis. Japanese Journal of Infectious Diseases. 2017; 70 (1): 19–25. doi: 10.7883/yoken.JJID.2015.652.
20. Ghazvini H., Taheri K., Edalati E., Sedighi M., Mirkalantari S. Virulence factors and antimicrobial resistance in uropathogenic Escherichiacoli strains isolated from cystitis and pyelonephritis. Turkish Journal of Medical Sciences. 2019; 49 (1); 361–367. doi: 10.3906/sag-1805-100.
21. Bukharin O. V. Persistentsiya patogennykh bakteriy = Persistence of pathogenic bacteria. Moscow: Meditsina; 1999: 367 p. (In Russ.).
22. Govindarajan D. K., Kandaswamy K. Virulence factors of uropathogens and their role in host pathogen interactions. Cellular Surfing. 2022; 8: 100075. doi: 10.1016/j.tcsw.2022.100075.
23. Qin X., Hu F., Wu S., Ye X., Zhu D., Zhang Y., Wang M. Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains. PLoS One. 2013; 8 (4): e61169–e61169. doi: 10.1371/journal.pone.0061169.
Review
For citations:
Naboka J.L., Gudima I.A., Kogan M.I., Jalagoniya K.T., Chernitskaya M.L., Kudrya E.V., Ivannikova E.V., Beloglasova N.N. Bioprofiles of gram-negative bacteria with recurrent lower urinary tract infection. Astrakhan medical journal. 2025;20(3):78-87. (In Russ.) https://doi.org/10.17021/1992-6499-2025-3-78-87
JATS XML


















